SEC Form 4 · accession 0001209191-17-014959
EXACTECH INC · EXAC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Bruce E Thompson
Officer — Sr VP, Biologics & Spine
Period of report
Feb 23, 2017
Accepted (ET)
Feb 27, 2017 · 7:06 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000913165
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 23, 2017 | M | 3,306 | $18.95 | A | 27,937 | D | |
| Common Stock | Feb 23, 2017 | S | 3,306 | $24.75 | D | 24,631 | D | |
| Common Stock | Feb 24, 2017 | M | 1,600 | $18.95 | A | 26,231 | D | |
| Common Stock | Feb 24, 2017 | S | 1,600 | $24.82 | D | 24,631 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Incentive/Non-Qualified Stock Option (right to buy) | $18.95 | Feb 23, 2016 | M | 3,306 | D | Feb 2, 2014 | Feb 28, 2017 | Common Stock | 5,900 | 2,594 | D |
| Incentive/Non-Qualified Stock Option (right to buy) | $18.95 | Feb 24, 2017 | M | 1,600 | D | Feb 2, 2014 | Feb 28, 2017 | Common Stock | 5,900 | 994 | D |
| Incentive/Non-Qualified Stock Option (right to buy) | $16.33 | holding | — | — | — | Feb 22, 2017 | Feb 22, 2019 | Common Stock | 23,800 | 23,800 | D |
| Incentive/Non-Qualified Stock Option (right to buy)F1 | $18.55 | holding | — | — | — | Feb 25, 2018 | Feb 25, 2020 | Common Stock | 20,000 | 20,000 | D |
| Non-Qualified Stock Option (right to buy)F2 | $20.90 | holding | — | — | — | May 9, 2019 | May 9, 2021 | Common Stock | 12,000 | 12,000 | D |
| Non-Qualified Stock Option (right to buy)F3 | $23.28 | holding | — | — | — | Apr 29, 2020 | Apr 29, 2022 | Common Stock | 9,000 | 9,000 | D |
Explanation of responses
- F1Such options are currently exercisable as regards 16,000 of the covered shares. The remaining options are exercisable, as regards 4,000 of the covered shares, on the fifth anniversary of the date of grant.
- F2Such options are currently exercisable as regards 4,800 of the covered shares. The remaining options are exercisable, as regards 2,400 of the covered shares, on the third anniversary of the date of grant, as regards 2,400 of the covered shares on the fourth anniversary of the date of grant, and as regards 2,400 of the covered shares, on the fifth anniversary of the date of grant.
- F3Such options are currently exercisable as regards 1,800 of the covered shares. The remaining options are exercisable, as regards 1,800 of the covered shares, on the second anniversary of the date of grant, as regards 1,800 of the covered shares, on the third anniversary of the date of grant, as regards 1,800 of the covered shares on the fourth anniversary of the date of grant, and as regards 1,800 of the covered shares, on the fifth anniversary of the date of grant.